European Healthtech startup funding raised during January 2022.
In January 2022, 65 European Healthtech companies raised a combined €1.0B across 65 funding rounds, up 62.6% versus January 2021. Netherlands led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Patient21 | Other | Jan 2022 | €126M |
| Leyden Labs | Series B | Jan 2022 | €124M |
| Ori Biotech | Series B | Jan 2022 | €88M |
| DistalMotion | Series D+ |
| Jan 2022 |
| €1.7B |
| Optima | Acquisition | Jan 2022 | €162M |
| Jan 2022 |
| €80M |
| Ambagon Therapeutics | Series A | Jan 2022 | €75M |
| InnovHeart | Series C | Jan 2022 | €49M |
| Engitix | Series A | Jan 2022 | €48M |
| SafeHeal | Other | Jan 2022 | €40M |
| Resilience | Other | Jan 2022 | €40M |
| DNA Script | Series C | Jan 2022 | €31M |
| Infermedica | Other | Jan 2022 | €27M |
| Zoi | Seed | Jan 2022 | €20M |
| SeqOne | Other | Jan 2022 | €20M |
| SeqOne Genomics | Series A | Jan 2022 | €20M |
| Onk Therapeutics | Series A | Jan 2022 | €19M |
